# Moderna ve Merck'ten kişiselleştirilmiş kanser aşısı başarısı

- **Source:** [US Top News and Analysis](https://brifing.si/source/635540e9-943e-450d-ae52-ae0bfe3b67eb)
- **Published:** 2026-08-19
- **Topic:** [Business](https://brifing.si/c/business)
- **Original article:** <https://www.cnbc.com/2026/08/19/moderna-merck-cancer-vaccine-shows-initial-late-stage-melanoma-data.html>
- **On Brifing:** https://brifing.si/s/8bce9742-db14-4259-b750-48eddc01f11e



## Sources covering this story

- [Ars Technica - All content — Moderna ve Merck'ten mRNA kanser aşısında başarı](https://arstechnica.com/health/2026/08/mrna-cancer-vaccine-succeeded-in-phase-3-melanoma-trial-moderna-and-merck-say/)
- [US Top News and Analysis — Moderna ve Merck'in kişiselleştirilmiş kanser aşısı umut vaat ediyor](https://www.cnbc.com/2026/08/19/moderna-merck-cancer-vaccine-shows-initial-late-stage-melanoma-data.html)

---

_Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._
